AccScience Publishing / IJB / Volume 12 / Issue 5 / DOI: 10.36922/IJB026320337
Submit to IJB
Cite this article
23
Download
651
Views
Related Info Links
Google Scholar
More by Authors Links
Haiyan Yao
Aiming Zhang
Zhen Yang
Journal Browser
Volume | Year
Issue
Search
News and Announcements
View All
REVIEW ARTICLE

Intelligent bioprinting: Smart bioinks, closed-loop biofabrication, and precision therapeutics

Fanfan Zhou1,2,3† ,  Xingfei Li1† ,  Jingtian Chen4 ,  Wanxiang Yao3 ,  Yuzhi Lin3 ,  Zhaoyu Chen1,2 ,  Hu Li1,2 ,  Haiyan Yao3* ,  Aiming Zhang3* ,  Zhen Yang1,2*
Show Less
1 Peking University People’s Hospital, Beijing , China
2 Arthritis Clinical and Research Center, Peking University People’s Hospital, Beijing , China
3 Department of Spine Surgery, Zhongshan People’s Hospital, Zhongshan, Guangdong , China
4 Department of Biomedical Engineering, Sichuan University, Chengdu, Sichuan , China
†These authors contributed equally to this work.
IJB 2026, 12(5), 026320337 https://doi.org/10.36922/IJB026320337
Received: 4 August 2026 | Revised: 5 September 2026 | Accepted: 9 September 2026 | Published online: 9 September 2026
© 2026 by the Author(s). This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 International License ( https://creativecommons.org/licenses/by/4.0/ )
Download PDF
XML
Cite
Abstract

Three-dimensional bioprinting is moving beyond anatomical fabrication toward systems that can respond to biological cues, use process data to guide manufacturing, and support patient-specific applications. Rather than treating every responsive material, artificial-intelligence model, or sensor-equipped platform as intelligent, this review uses four descriptive functions—responsiveness, observability, decision capability, and actuation—to compare the field across three operational categories: responsive components, intelligence-assisted systems, and validated closed-loop systems. These functions are not cumulative prerequisites: responsiveness can exist without sensing, and closed-loop control can operate without a responsive bioink. We synthesize smart bioinks and printing quality, intelligent strategy selection, data-driven monitoring and feedback, post-printing maturation, and regenerative or precision-therapeutic applications. Representative evidence indicates that the most credible closed loops currently address fast manufacturing variables such as extrusion and geometry, whereas biological feedback over hours to weeks, continuously updated digital twins, and high-level autonomy remain early. We also distinguish the evidence needs of implantable regenerative constructs from those of patient-derived drug-testing models. The contribution of this review is therefore a cross-domain functional classification and translational evidence hierarchy, rather than a claim that smart materials, AI-assisted design, or closed-loop bioprinting are themselves new.

Graphical abstract
Keywords
Intelligent bioprinting
Smart bioinks
Closed-loop biofabrication
Biosensing
Regenerative medicine
Disease models
Precision therapeutics
Funding
This work was financially supported by the Peking University Medicine Fund of Fostering Young Scholars’ Scientific & Technological Innovation (BMU2026YFJHPY022), Peking University People’s Hospital Scientific Research Development Funds (RDEB2025-04), and Bone and Joint Science and Technology Talent Innovation Development Project (GSKQNJJ-2025-001).
Conflict of interest
The authors declare they have no competing interests.
References
  1. Ng WL, Bartolo P. 3D bioprinting of tissues and organs for systemic diseases and localized injuries. Mil Med Res. 2026;13(1):100006. doi: 10.1016/j.mmr.2026.100006
  2. Agarwal T, Onesto V, Banerjee D, et al. 3D bioprinting in tissue engineering: current state-of-the-art and challenges towards system standardization and clinical translation. Biofabrication. 2025;17(4):042003. doi: 10.1088/1758-5090/ade47a
  3. Murphy SV, Atala A. 3D bioprinting of tissues and organs. Nat Biotechnol. 2014;32(8):773-785. doi: 10.1038/nbt.2958
  4. Moroni L, Burdick JA, Highley C, et al. Biofabrication strategies for 3D in vitro models and regenerative medicine. Nat Rev Mater. 2018;3(5):21-37. doi: 10.1038/s41578-018-0006-y
  5. Heinrich MA, Liu W, Jimenez A, et al. 3D bioprinting: from benches to translational applications. Small. 2019;15(23):e1805510. doi: 10.1002/smll.201805510
  6. Zhang YS, Haghiashtiani G, Hübscher T, et al. 3D extrusion bioprinting. Nat Rev Methods Primers. 2021;1(1):75. doi: 10.1038/s43586-021-00073-8
  7. Levato R, Jungst T, Scheuring RG, Blunk T, Groll J, Malda J. From shape to function: the next step in bioprinting. Adv Mater. 2020;32(12):1906423. doi: 10.1002/adma.201906423
  8. Sun W, Starly B, Daly AC, et al. The bioprinting roadmap. Biofabrication. 2020;12(2):022002. doi: 10.1088/1758-5090/ab5158
  9. Matai I, Kaur G, Seyedsalehi A, McClinton A, Laurencin CT. Progress in 3D bioprinting technology for tissue/organ regenerative engineering. Biomaterials. 2020;226:119536. doi: 10.1016/j.biomaterials.2019.119536
  10. Chiesa I, Batoni E, Bonatti AF, et al. New frontiers in bioengineering: a perspective on the open challenges in bioprinting. Int J Bioprint. 2026;12(2):025500517. doi: 10.36922/IJB025500517
  11. An J, Chua CK, Mironov V. Application of machine learning in 3D bioprinting: focus on development of big data and digital twin. Int J Bioprint. 2021;7(1):342. doi: 10.18063/ijb.v7i1.342
  12. Chen H, Zhang B, Huang J. Recent advances and applications of artificial intelligence in 3D bioprinting. Biophys Rev (Melville). 2024;5(3):031301. doi: 10.1063/5.0190208
  13. Ke D. AI-driven closed-loop extrusion-based bioprinting system: from dynamic regulation to medical translation. Bioprinting. 2026;54:e00459. doi: 10.1016/j.bprint.2025.e00459
  14. Tănase M, Veres C, Szabo DA. Artificial intelligence in biomedical 3D printing: mapping the evidence. J Manuf Mater Process. 2025;9(12):407. doi: 10.3390/jmmp9120407
  15. Zhu Z, Ng DWH, Park HS, McAlpine MC. 3D-printed multifunctional materials enabled by artificial-intelligence-assisted fabrication technologies. Nat Rev Mater. 2021;6(1):27-47. doi: 10.1038/s41578-020-00235-2
  16. Amukarimi S, Rezvani Z, Eghtesadi N, Mozafari M. Smart biomaterials: from 3D printing to 4D bioprinting. Methods. 2022;205:191-199. doi: 10.1016/j.ymeth.2022.07.006
  17. Zhang Z, Zhou X, Fang Y, et al. AI-driven 3D bioprinting for regenerative medicine: from bench to bedside. Bioact Mater. 2025;45:201-230. doi: 10.1016/j.bioactmat.2024.11.021
  18. Liu S, Kaur N, Song DH, Moses JC, Ozbolat IT. Self-driving bioprinting laboratories. Biofabrication. 2026;18(1):013001. doi: 10.1088/1758-5090/ae3645
  19. Jergitsch M, Mateos-Timoneda MA. 3D extrusion bioprinting: rational bioink design and advanced fabrication techniques. Trends Biotechnol. 2026;44(2):378-388. doi: 10.1016/j.tibtech.2025.06.008
  20. Ng WL, Shkolnikov V. Jetting-based bioprinting: process, dispense physics, and applications. Bio-Des Manuf. 2024;7:771-799. doi: 10.1007/s42242-024-00285-3
  21. Ng WL, Paula CTB, Serra AC, Coelho JFJ, Bartolo P. Vat photopolymerization-based bioprinting: shaping next-generation tissues with light. Interdiscip Med. 2026;4(1):e70078. doi: 10.1002/inmd.70078
  22. Ozbolat IT, Hospodiuk M. Current advances and future perspectives in extrusion-based bioprinting. Biomaterials. 2016;76:321-343. doi: 10.1016/j.biomaterials.2015.10.076
  23. Schwab A, Levato R, D'Este M, Piluso S, Eglin D, Malda J. Printability and shape fidelity of bioinks in 3D bioprinting. Chem Rev. 2020;120(19):11028-11055. doi: 10.1021/acs.chemrev.0c00084
  24. Lui YS, Sow WT, Tan LP, Wu Y, Lai Y, Li H. 4D printing and stimuli-responsive materials in biomedical aspects. Acta Biomater. 2019;92:19-36. doi: 10.1016/j.actbio.2019.05.005
  25. Rahimnejad M, Jahangiri S, Kiadeh SZH, et al. Stimuli-responsive biomaterials: smart avenue toward 4D bioprinting. Crit Rev Biotechnol. 2024;44(5):860-891. doi: 10.1080/07388551.2023.2213398
  26. Waidi YO, Gugulothu SB. 4D bioprinting of protein-based bioinks for tissue engineering and disease models. Biomater Sci. 2026;14:356-376. doi: 10.1039/D5BM01284H
  27. Luo Y, Lin X, Chen B, Wei X. Cell-laden four-dimensional bioprinting using near-infrared-triggered shape-morphing alginate/polydopamine bioinks. Biofabrication. 2019;11(4):045019. doi: 10.1088/1758-5090/ab39c5
  28. Freeman S, Calabro S, Williams R, Jin S, Ye K. Bioink formulation and machine learning-empowered bioprinting optimization. Front Bioeng Biotechnol. 2022;10:913579. doi: 10.3389/fbioe.2022.913579
  29. Limon SM, Sarah R, Habib A. Integrating decision trees and clustering for efficient optimization of bioink rheology and 3D bioprinted construct microenvironments. J Manuf Sci Eng. 2025;147(9):091003. doi: 10.1115/1.4068429
  30. Sarah R, Rohauer R, Schimmelpfennig K, Limon SM, Lewis CL, Habib A. Data-driven optimization of bioink formulations for extrusion-based bioprinting: a predictive modeling approach. J Manuf Sci Eng. 2025;147(10):101001. doi: 10.1115/1.4069041
  31. Sarah R, Schimmelpfennig K, Rohauer R, Lewis CL, Limon SM, Habib A. Characterization and machine learning-driven property prediction of a novel hybrid hydrogel bioink considering extrusion-based 3D bioprinting. Gels. 2025;11(1):45. doi: 10.3390/gels11010045
  32. Sergis V, Kelly D, Pramanick A, Britchfield G, Mason K, Daly AC. In-situ quality monitoring during embedded bioprinting using integrated microscopy and classical computer vision. Biofabrication. 2025;17(2):025004. doi: 10.1088/1758-5090/adaa22
  33. Gugliandolo SG, Prioglio E, Moscatelli D, Colosimo BM. A new solution for in situ monitoring of shape fidelity in extrusion-based bioprinting via thermal imaging. Int J Bioprint. 2024;10(3):2021. doi: 10.36922/ijb.2021
  34. Kelly D, Sergis V, Ventura i Blanco L, Mason K, Daly AC. Autonomous control of extrusion bioprinting using convolutional neural networks. Adv Funct Mater. 2025;35(30):2424553. doi: 10.1002/adfm.202424553
  35. Wang L, Xu ME, Luo L, Zhou Y, Si P. Iterative feedback bio-printing-derived cell-laden hydrogel scaffolds with optimal geometrical fidelity and cellular controllability. Sci Rep. 2018;8(1):2802. doi: 10.1038/s41598-018-21274-4
  36. Wang H, Yu H, Zhou X, et al. An overview of extracellular matrix-based bioinks for 3D bioprinting. Front Bioeng Biotechnol. 2022;10:905438. doi: 10.3389/fbioe.2022.905438
  37. Rastin H, Zhang B, Bi J, Hassan K, Tung TT, Losic D. 3D printing of cell-laden electroconductive bioinks for tissue engineering applications. J Mater Chem B. 2020;8(27):5862-5876. doi: 10.1039/D0TB00627K
  38. Almeida D, Küppers F, Gusmão A, et al. Design of magnetic kappa-carrageenan-collagen bioinks for 3D bioprinting. J Mater Sci. 2024;59(31):14573-14592. doi: 10.1007/s10853-024-10021-y
  39. Ng WL, Yeow CHE, Huang X, Lee S, Yeong WY. Physically crosslinked gelatin bio-inks with enhanced printability, degradation and mechanical robustness for multi-modal bioprinting. Interdiscip Med. 2025;3(4):e20250058. doi: 10.1002/INMD.20250058
  40. Yadav J, Chahal S, Kumar P, Kumar C. Thermo-responsive smart hydrogels: molecular engineering, dynamic cross-linking strategies, and therapeutics applications. Gels. 2026;12(1):12. doi: 10.3390/gels12010012
  41. Pu M, Cao H, Zhang H, et al. ROS-responsive hydrogels: from design and additive manufacturing to biomedical applications. Mater Horiz. 2024;11(16):3721-3746. doi: 10.1039/D4MH00289J
  42. Jongprasitkul H, Parihar VS, Turunen S, Kellomäki M. pH-responsive gallol-functionalized hyaluronic acid-based tissue adhesive hydrogels for injection and three-dimensional bioprinting. ACS Appl Mater Interfaces. 2023;15(28):33972-33984. doi: 10.1021/acsami.3c02961
  43. Zhang Z, Tao ZZ, Du R, Huo R, Zheng X. Artificial intelligence informed hydrogel biomaterials in additive manufacturing. Gels. 2025;11(12):981. doi: 10.3390/gels11120981
  44. Morgan FLC, Moroni L, Baker MB. Dynamic bioinks to advance bioprinting. Adv Healthc Mater. 2020;9(15):1901798. doi: 10.1002/adhm.201901798
  45. Morgan FLC, Fernández-Pérez J, Moroni L, Baker MB. Tuning hydrogels by mixing dynamic cross-linkers: enabling cell-instructive hydrogels and advanced bioinks. Adv Healthc Mater. 2022;11(1):e2101576. doi: 10.1002/adhm.202101576
  46. Tournier P, Saint-Pé G, Lagneau N, et al. Clickable dynamic bioinks enable post-printing modifications of construct composition and mechanical properties controlled over time and space. Adv Sci (Weinh). 2023;10(30):e2300055. doi: 10.1002/advs.202300055
  47. Ning L, Gil CJ, Hwang B, et al. Biomechanical factors in three-dimensional tissue bioprinting. Appl Phys Rev. 2020;7(4):041319. doi: 10.1063/5.0023206
  48. Chakraborty A, Roy A, Ravi SP, Paul A. Exploiting the role of nanoparticles for use in hydrogel-based bioprinting applications: concept, design, and recent advances. Biomater Sci. 2021;9(19):6337-6354. doi: 10.1039/D1BM00605C
  49. Chen P, Zheng L, Wang Y, et al. Desktop-stereolithography 3D printing of a radially oriented extracellular matrix/mesenchymal stem cell exosome bioink for osteochondral defect regeneration. Theranostics. 2019;9(9):2439-2459. doi: 10.7150/thno.31017
  50. Han P, Ivanovski S. 3D bioprinted extracellular vesicles for tissue engineering—a perspective. Biofabrication. 2023;15(1):013001. doi: 10.1088/1758-5090/ac9809
  51. Elkhoury K, Chen M, Koçak P, et al. Hybrid extracellular vesicles-liposome incorporated advanced bioink to deliver microRNA. Biofabrication. 2022;14(4):045008. doi: 10.1088/1758-5090/ac8621
  52. Bar A, Kryukov O, Etzion S, Cohen S. Engineered extracellular vesicle-mediated delivery of miR-199a-3p increases the viability of 3D-printed cardiac patches. Int J Bioprint. 2023;9(2):670. doi: 10.18063/ijb.v9i2.670
  53. Bakht SM, Pardo A, Gómez-Florit M, Reis RL, Domingues RMA, Gomes ME. Engineering next-generation bioinks with nanoparticles: moving from reinforcement fillers to multifunctional nanoelements. J Mater Chem B. 2021;9(25):5025-5038. doi: 10.1039/D1TB00717C
  54. Zhang J, Ren F, Bu F, Yao Y, Li M. 3D bioprinting-driven strategies for tissue regeneration and controlled immune modulation. Int J Bioprint. 2026;12(1):173-198. doi: 10.36922/IJB025460474
  55. Peng YH, Hsiao SK, Gupta K, et al. Dynamic matrices with DNA-encoded viscoelasticity for cell and organoid culture. Nat Nanotechnol. 2023;18(12):1463-1473. doi: 10.1038/s41565-023-01483-3
  56. Xu Y, Sarah R, Habib A, Liu Y, Khoda B. Constraint based Bayesian optimization of bioink precursor: a machine learning framework. Biofabrication. 2024;16(4):045031. doi: 10.1088/1758-5090/ad716e
  57. Wu C, Xu Y, Fang J, Li Q. Machine learning in biomaterials, biomechanics/mechanobiology, and biofabrication: state of the art and perspective. Arch Comput Methods Eng. 2024;31(7):3699-3765. doi: 10.1007/s11831-024-10100-y
  58. Law ACW, Wang R, Chung J, et al. Process parameter optimization for reproducible fabrication of layer porosity quality of 3D-printed tissue scaffold. J Intell Manuf. 2024;35(4):1825-1844. doi: 10.1007/s10845-023-02141-0
  59. Ng WL, Vyas C, Huang B, Yeong WY, Bartolo P. Advanced bioprinting strategies for fabrication of biomimetic tissues and organs. Int J Extrem Manuf. 2025;7(6):062006. doi: 10.1088/2631-7990/adeee0
  60. Lamberger Z, Schubert DW, Buechner M, et al. Advanced optical assessment and modeling of extrusion bioprinting. Sci Rep. 2024;14(1):13972. doi: 10.1038/s41598-024-64039-y
  61. Wang B, Sanli A, Lai Z, et al. Next-generation biosensing for in situ monitoring. Nat Sens. 2026;1:111-130. doi: 10.1038/s44460-025-00016-w
  62. Byrne R, Carrico A, Lettieri M, et al. Bioinks and biofabrication techniques for biosensors development: a review. Mater Today Bio. 2024;28:101185. doi: 10.1016/j.mtbio.2024.101185
  63. Trampe E, Koren K, Akkineni AR, et al. Functionalized bioink with optical sensor nanoparticles for O2 imaging in 3D-bioprinted constructs. Adv Funct Mater. 2018;28(45):1804411. doi: 10.1002/adfm.201804411
  64. Haring AP, Jiang S, Barron C, et al. 3D bioprinting using hollow multifunctional fiber impedimetric sensors. Biofabrication. 2020;12(3):035026. doi: 10.1088/1758-5090/ab94d0
  65. Lee J, Maji S, Lee H. Fabrication and integration of a low-cost 3D printing-based glucose biosensor for bioprinted liver-on-a-chip. Biotechnol J. 2023;18(12):e2300154. doi: 10.1002/biot.202300154
  66. Marzi J, Fuhrmann E, Brauchle E, et al. Non-invasive three-dimensional cell analysis in bioinks by Raman imaging. ACS Appl Mater Interfaces. 2022;14(27):30455-30465. doi: 10.1021/acsami.1c24463
  67. Fitzgerald S, Akhtar J, Schartner E, Ebendorff-Heidepriem H, Mahadevan-Jansen A, Li J. Multimodal Raman spectroscopy and optical coherence tomography for biomedical analysis. J Biophotonics. 2023;16(3):e202200231. doi: 10.1002/jbio.202200231
  68. Bergholt MS, Serio A, Albro MB. Raman spectroscopy: guiding light for the extracellular matrix. Front Bioeng Biotechnol. 2019;7:303. doi: 10.3389/fbioe.2019.00303
  69. Zhu Z, Guo SZ, Hirdler T, et al. 3D printed functional and biological materials on moving freeform surfaces. Adv Mater. 2018;30(23):e1707495. doi: 10.1002/adma.201707495
  70. Strauß S, Schroth B, Hubbuch J. Evaluation of the reproducibility and robustness of extrusion-based bioprinting processes applying a flow sensor. Front Bioeng Biotechnol. 2022;10:831350. doi: 10.3389/fbioe.2022.831350
  71. Bradshaw TM, Johnson CR, Broberg CA, et al. Sterilization effects on nitric oxide-releasing glucose sensors. Sens Actuators B Chem. 2024;405:135311. doi: 10.1016/j.snb.2024.135311
  72. Ben-Aissa S, Tripathy S, Cass AEG. Implantable electrochemical biosensors: challenges, strategies, and applications. Curr Opin Electrochem. 2025;54:101745. doi: 10.1016/j.coelec.2025.101745
  73. Thangadurai M, Srinivasan SS, Sekar MP, Sethuraman S, Sundaramurthi D. Emerging perspectives on 3D printed bioreactors for clinical translation of engineered and bioprinted tissue constructs. J Mater Chem B. 2024;12:350-381. doi: 10.1039/D3TB01847D
  74. Xia X, Leng T, Garcia AJ, et al. Machine learning for biomaterials design. Nat Rev Bioeng. Published online August 25, 2026. doi: 10.1038/s44222-026-00476-w
  75. Ding C, Luo Y, Yu X, et al. Recent advances in multimodal foundation model-enabled peptide screening and optimization for smart biomaterials and functional tissue engineering. Front Bioeng Biotechnol. 2026;14:1884032. doi: 10.3389/fbioe.2026.1884032
  76. Daly AC, Cunniffe GM, Sathy BN, Jeon O, Alsberg E, Kelly DJ. 3D bioprinting of developmentally inspired templates for whole bone organ engineering. Adv Healthc Mater. 2016;5(18):2353-2362. doi: 10.1002/adhm.201600182
  77. Oliveira JM, Ribeiro VP, Reis RL. Advances on gradient scaffolds for osteochondral tissue engineering. Prog Biomed Eng. 2021;3(3):033001. doi: 10.1088/2516-1091/abfc2c
  78. Lesage C, Lafont M, Guihard P, et al. Material-assisted strategies for osteochondral defect repair. Adv Sci (Weinh). 2022;9(16):2200050. doi: 10.1002/advs.202200050
  79. Li H, Yang Y, Wang C, et al. Analysis of three-dimensional printing strategies for meniscus/articular disc repair and regeneration. Tissue Eng Part B Rev. 2025;31(5):446-465. doi: 10.1089/ten.teb.2024.0233
  80. Yang Z, Cao F, Li H, et al. Microenvironmentally optimized 3D-printed TGFβ-functionalized scaffolds facilitate endogenous cartilage regeneration in sheep. Acta Biomater. 2022;150:181-198. doi: 10.1016/j.actbio.2022.07.029
  81. Yang Z, Zhao T, Gao C, et al. 3D-bioprinted difunctional scaffold for in situ cartilage regeneration based on aptamer-directed cell recruitment and growth factor-enhanced cell chondrogenesis. ACS Appl Mater Interfaces. 2021;13(20):23369-23383. doi: 10.1021/acsami.1c01844
  82. Rhee S, Puetzer JL, Mason BN, Reinhart-King CA, Bonassar LJ. 3D bioprinting of spatially heterogeneous collagen constructs for cartilage tissue engineering. ACS Biomater Sci Eng. 2016;2(10):1800-1805. doi: 10.1021/acsbiomaterials.6b00288
  83. Ji Y, Lv Z, Jin H, Chen J, Tang X. Three-dimensional bioprinting in tendon/ligament-bone interface regeneration: from design innovations to performance enhancement. Int J Bioprint. 2026;12(1):1-18. doi: 10.36922/IJB025410419
  84. Koffler J, Zhu W, Qu X, et al. Biomimetic 3D-printed scaffolds for spinal cord injury repair. Nat Med. 2019;25(2):263-269. doi: 10.1038/s41591-018-0296-z
  85. Hakimi N, Cheng R, Leng L, et al. Handheld skin printer: in situ formation of planar biomaterials and tissues. Lab Chip. 2018;18(10):1440-1451. doi: 10.1039/C7LC01236E
  86. Albanna M, Binder KW, Murphy SV, et al. In situ bioprinting of autologous skin cells accelerates wound healing of extensive excisional full-thickness wounds. Sci Rep. 2019;9(1):1856. doi: 10.1038/s41598-018-38366-w
  87. Zheng Z, Tan X, Liang H, Li L, Jiang Q, Shi J. In situ bioprinting: control strategies, bioinks, applications, challenges, and future perspectives. Int J Bioprint. 2026;12(3):026200196. doi: 10.36922/IJB026200196
  88. Bejleri D, Streeter BW, Nachlas ALY, et al. A bioprinted cardiac patch composed of cardiac-specific extracellular matrix and progenitor cells for heart repair. Adv Healthc Mater. 2018;7(23):e1800672. doi: 10.1002/adhm.201800672
  89. Kong M, Wu Z, Zheng Z, et al. Construction strategies for 3D printed cardiac tissue repair materials and their application potential. Interdiscip Med. 2025;3(3):e20240085. doi: 10.1002/INMD.20240085
  90. Kolesky DB, Truby RL, Gladman AS, Busbee TA, Homan KA, Lewis JA. 3D bioprinting of vascularized, heterogeneous cell-laden tissue constructs. Adv Mater. 2014;26(19):3124-3130. doi: 10.1002/adma.201305506
  91. Grigoryan B, Paulsen SJ, Corbett DC, et al. Multivascular networks and functional intravascular topologies within biocompatible hydrogels. Science. 2019;364(6439):458-464. doi: 10.1126/science.aav9750
  92. Skylar-Scott MA, Uzel SGM, Nam LL, et al. Biomanufacturing of organ-specific tissues with high cellular density and embedded vascular channels. Sci Adv. 2019;5(9):eaaw2459. doi: 10.1126/sciadv.aaw2459
  93. Skardal A, Aleman J, Forsythe S, et al. Drug compound screening in single and integrated multi-organoid body-on-a-chip systems. Biofabrication. 2020;12(2):025017. doi: 10.1088/1758-5090/ab6d36
  94. De Spirito M, Palmieri V, Perini G, Papi M. Bridging the gap: integrating 3D bioprinting and microfluidics for advanced multi-organ models in biomedical research. Bioengineering (Basel). 2024;11(7):664. doi: 10.3390/bioengineering11070664
  95. Ma W, Lu H, Xiao Y, Wu C. Advancing organoid development with 3D bioprinting. Organoid Res. 2025;1(1):025040004. doi: 10.36922/OR025040004
  96. Neufeld L, Yeini E, Pozzi S, Satchi-Fainaro R. 3D bioprinted cancer models: from basic biology to drug development. Nat Rev Cancer. 2022;22(12):679-692. doi: 10.1038/s41568-022-00514-w
  97. Napoli GC, Figg WD, Chau CH. Functional drug screening in the era of precision medicine. Front Med (Lausanne). 2022;9:912641. doi: 10.3389/fmed.2022.912641
  98. Yi HG, Jeong YH, Kim Y, et al. A bioprinted human-glioblastoma-on-a-chip for the identification of patient-specific responses to chemoradiotherapy. Nat Biomed Eng. 2019;3(7):509-519. doi: 10.1038/s41551-019-0363-x
  99. Neufeld L, Yeini E, Reisman N, et al. Microengineered perfusable 3D-bioprinted glioblastoma model for in vivo mimicry of tumor microenvironment. Sci Adv. 2021;7(34):eabi9119. doi: 10.1126/sciadv.abi9119
  100. Sun H, Sun L, Ke X, et al. Prediction of clinical precision chemotherapy by patient-derived 3D bioprinting models of colorectal cancer and its liver metastases. Adv Sci (Weinh). 2024;11(2):e2304460. doi: 10.1002/advs.202304460
  101. Alhattab DM, Isaioglou I, Alshehri S, et al. Fabrication of a three-dimensional bone marrow niche-like acute myeloid leukemia disease model by an automated and controlled process using a robotic multicellular bioprinting system. Biomater Res. 2023;27(1):111. doi: 10.1186/s40824-023-00457-9
  102. Shukla P, Bera AK, Yeleswarapu S, Pati F. High throughput bioprinting using decellularized adipose tissue-based hydrogels for 3D breast cancer modeling. Macromol Biosci. 2024;24(8):2400035. doi: 10.1002/mabi.202400035
  103. Zhao J, Shen F, Sheng S, et al. Cartilage-on-chip for osteoarthritis drug screening. Organoid Res. 2025;1(1):8461. doi: 10.36922/or.8461
  104. Sarkar N, Bhumiratana S, Geris L, Papantoniou I, Grayson WL. Bioreactors for engineering patient-specific tissue grafts. Nat Rev Bioeng. 2023;1(5):361-377. doi: 10.1038/s44222-023-00036-6
  105. Perin F, Ouyang L, Lim KS, et al. Bioprinted constructs in the regulatory landscape: current state and future perspectives. Adv Mater. 2026;38(4):e04037. doi: 10.1002/adma.202504037
  106. ASTM International. ASTM F3659-24: Standard Guide for Bioinks Used in Bioprinting. ASTM International; 2024. doi: 10.1520/F3659-24
  107. US Food and Drug Administration. Technical Considerations for Additive Manufactured Medical Devices: Guidance for Industry and Food and Drug Administration Staff. US Food and Drug Administration; 2017. Accessed August 2, 2026. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/technical-considerations-additive-manufactured-medical-devices
  108. European Parliament and Council. Regulation (EC) No 1394/2007 of the European Parliament and of the Council of 13 November 2007 on advanced therapy medicinal products and amending Directive 2001/83/EC and Regulation (EC) No 726/2004. Off J Eur Union. 2007;L324:121-137. Accessed August 2, 2026. https://eur-lex.europa.eu/eli/reg/2007/1394/oj/eng
  109. 109. European Commission. EudraLex Volume 4: Good Manufacturing Practice Guidelines, Part IV: GMP Requirements for Advanced Therapy Medicinal Products. European Commission. Accessed August 2, 2026. https://health.ec.europa.eu/medicinal-products/eudralex/eudralex-volume-4_en
Share
Back to top
International Journal of Bioprinting, Electronic ISSN: 2424-8002 Print ISSN: 2424-7723, Published by AccScience Publishing
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here
Accept